Alvotech (ALVO)
5.19
-0.13
(-2.44%)
USD |
NASDAQ |
Sep 08, 16:00
5.13
-0.06
(-1.16%)
Pre-Market: 08:30
Alvotech Total Liabilities (Quarterly) : 1.779B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.779B |
| March 31, 2026 | 1.703B |
| December 31, 2025 | 1.772B |
| September 30, 2025 | 1.586B |
| June 30, 2025 | 1.566B |
| March 31, 2025 | 1.548B |
| December 31, 2024 | 1.634B |
| September 30, 2024 | 1.577B |
| June 30, 2024 | 1.674B |
| March 31, 2024 | 1.719B |
| December 31, 2023 | 1.883B |
| September 30, 2023 | 1.620B |
| Date | Value |
|---|---|
| June 30, 2023 | 1.389B |
| March 31, 2023 | 1.551B |
| December 31, 2022 | 1.393B |
| September 30, 2022 | 960.36M |
| June 30, 2022 | |
| March 31, 2022 | 22.48M |
| December 31, 2021 | 25.80M |
| September 30, 2021 | 22.21M |
| June 30, 2021 | 23.41M |
| March 31, 2021 | 23.37M |
| December 31, 2020 | 30.61M |
| September 30, 2020 | 9.745M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | 32.10B |
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.587B |
| Shareholders Equity (Quarterly) | -191.48M |
| Debt to Equity Ratio | -7.582 |
| Current Ratio | 1.646 |
| Net Debt Paydown Yield | -3.42% |